Aprogen Medicines Inc. (KRX:007460)

South Korea flag South Korea · Delayed Price · Currency is KRW
739.00
-37.00 (-4.77%)
Last updated: Jan 30, 2026, 10:58 AM KST
-6.69%
Market Cap227.40B +3.9%
Revenue (ttm)126.09B -14.7%
Net Income-50.93B
EPS-175.67
Shares Out308.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,520,964
Average Volume3,808,041
Open774.00
Previous Close776.00
Day's Range732.00 - 774.00
52-Week Range556.00 - 938.00
Beta0.07
RSI56.16
Earnings DateMar 19, 2026

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam... [Read more]

Industry Conglomerates
Founded 1971
Employees 256
Stock Exchange Korea Stock Exchange
Ticker Symbol 007460
Full Company Profile

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.

Financial Statements